Round-up: Alternative proteins drive new production investments

Cultivated meat, insect protein and mycoprotein are among the technologies attracting investment as manufacturers expand their production capabilities.
Pet players in the UK, Finland, France and Spain are expanding their production capabilities, with projects spanning alternative proteins, ingredients and animal nutrition.
Meatly
UK-based cultivated meat company Meatly has relocated to Imperial College London’s Grapht Works facility in North Acton, London, as it prepares to begin production runs in 2027. The expansion is supported by the company’s £10.4 million (€12.5M/$14.0M) Series A funding round announced in May.
The facility will supply the UK pet food market, where the company secured the world’s first regulatory approval for cultivated meat in pet food.
Meatly CEO Owen Ensor tells GlobalPETS that establishing its own facility within Imperial’s biotech ecosystem at Grapht Works is the fastest and most capital-efficient route to achieving commercial-scale cultivated meat production.
“Our work so far has been at a pilot scale, most recently with our own 320-litre bioreactor. This new facility is designed to deliver a step-change in bioreactor capacity that lets us demonstrate commercial viability at scale and put products on shelves consistently,” he says.
The move forms part of Meatly’s ambition to create Europe’s largest cultivated meat facility. The company is currently focusing on installing its 20,000-litre bioreactor at Grapht Works, which, once completed, Meatly says will make it Europe’s largest cultivated meat production facility to date.
The relocation has enabled the company to move from a 1,000-square-foot laboratory to a facility of approximately 10,000 square feet.
Volare
The Finnish biotech startup has announced the completion of Volare 01, its first industrial-scale protein factory in Pori, Finland, approximately 250 km from Helsinki.
The 10,000-square-metre facility is designed to produce up to 5,000 tonnes of insect protein and 2,000 tonnes of insect oil annually from food-industry side streams.
“We’ve built it with four to 10 times lower capital costs, around 50% fewer employees and 30% less energy in end-product processing compared with competing solutions. A lot of that comes down to how we’ve designed the process, the automation and keeping engineering and project management in-house,” Volare CEO Jarna Hyvönen tells GlobalPETS.
According to Hyvönen, the new facility will serve a diverse range of industries, including pet food, aquafeed, other feed applications and the chemical industry.
Following the completion of Volare 01, the company is preparing for its next stage of expansion, with plans to build a second industrial-scale facility and replicate its production model across Europe and other markets. The expansion will be supported by €7.1 million ($8M) raised through Springvest, with backing from new and existing investors, including Maki.vc.
“Right now, our focus is commissioning and ramping up Volare 01, but we’re already planning the next factory and evaluating locations in Europe and beyond. Ideally, it will have roughly five times the protein capacity of Volare 01, around 20,000–30,000 tonnes a year,” Hyvönen says.
Volare’s protein has been used commercially since 2022, including in dog treats developed with Alvar Pet, Dagsmark’s insect-based cat food and rainbow trout feed produced in collaboration with Alltech Fennoaqua.
Seppic
French specialty chemicals and ingredients company Seppic has opened a new production unit at its Lons facility, around 460 km from Paris. The expansion will triple production capacity for natural extracts used in nutraceuticals and cosmetics. The facility also manufactures ingredients for the pet sector.
The new 1,400-square-metre building will triple production capacity for a patented, plant-derived active ingredient complex with clinically proven benefits for anti-aging, skin hydration and hair loss reduction.
The plant also manufactures a gluten-free wheat lipid extract developed to support skin and coat health in dogs. The ingredient is designed for use in oral pet supplements.
Enifer
Finnish biotech start-up Enifer has begun commissioning a new factory in Kantvik, in the municipality of Kirkkonummi, west of Helsinki, to produce its fungi-based protein.
The 3,000-tonne facility is expected to reach full production capacity in 2027, following an investment of €33 million ($37M).
The facility uses a continuous fungal fermentation process, in which liquid raw materials are fed into a steel tank where the fungus grows, Simo Ellilä, CEO and Co-Founder of Enifer, tells GlobalPETS.
“Once the fermentation is complete, excess water is removed and the remaining biomass is dried. At the heart of the process is the 150-square-metre fermenter, measuring 14.5 metres high,” he adds.
The factory will primarily supply the European pet food market, while selectively serving other geographies and applications. “The aim is to gradually start serving more food-grade ingredients over time, as regulatory approval allows, [for example] in the US, Singapore and eventually, Europe,” Ellilä says.
Norel Animal Nutrition
Norel Animal Nutrition, a Spanish feed manufacturer, has opened a new feed-additive production plant in Johor, Malaysia, which will supply the poultry, swine, ruminant, aquaculture and pet food sectors.
Located approximately 350 km from Kuala Lumpur, the facility has a reported annual capacity of 10,000 tonnes across four production lines.
The Johor plant expands Norel’s manufacturing footprint in Asia-Pacific, where it already operates a facility in India. The company also has an established commercial presence across the region, with products registered in markets from Japan to Indonesia, as well as Australia and New Zealand.
Founded in 1980 and headquartered in Madrid, Norel is present in more than 70 countries worldwide. Outside Asia-Pacific, it operates manufacturing facilities in Spain, the US, Mexico and Egypt.
Share this story:
One click prioritizes GlobalPETS in your search results and AI answers.
